Retraction Note: Stem Cell Research & Therapy (2021) 12:192
The Editors-in-Chief have retracted this article. An investigation by the Publisher has found a number of articles, including this one, which share similar concerns, involving but not limited to, irregularities with respect to submission and authorship. The Editors-in-Chief therefore no longer have confidence in the results and conclusions presented in this article. Alexander Markov, Lakshmi Thangavelu, and Ali Hassanzadeh do not agree to this retraction. Surendar Aravindhan, Angelina Olegovna Zekiy, Mostafa Jarahian, Max Stanley Chartrand, Yashwant Pathak, Faroogh Marofi and Somayeh Shamlou did not respond to correspondence from the Editor about this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13287-021-02265-1.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Markov, A., Thangavelu, L., Aravindhan, S. et al. Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 15, 110 (2024). https://doi.org/10.1186/s13287-024-03733-0
Published:
DOI: https://doi.org/10.1186/s13287-024-03733-0